Bone Mineral Density, Fracture, and Vitamin D in Adolescents and Young Women Using Depot Medroxyprogesterone Acetate

Journal of Pediatric and Adolescent Gynecology

Volumn 25, Issue 1, 2012, Pages 23-26

  Pitts, Sarah A B ^a   Feldman, Henry A ^a   Dorale, Amanda ^a   Gordon, Catherine M ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Adolescents; Bone mineral density; Contraception; Depot medroxyprogesterone acetate; Fracture; Vitamin D

Indexed keywords

MEDROXYPROGESTERONE ACETATE; VITAMIN D;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HIP; HUMAN; LUMBAR SPINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URBAN AREA; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; BONE DENSITY; BOSTON; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; FRACTURES, BONE; HUMANS; MEDROXYPROGESTERONE ACETATE; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; VITAMIN D; YOUNG ADULT;

EID: 84855331604     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2011.07.014     Document Type: Article

References (16)

1. Bogunovic L., Doyle S.M., Vogiatzi M.G. Measurement of bone density in the pediatric population. Curr Opin Pediatr 2009, 21:77.
2. Cundy T., Ames R., Horne A., et al. A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate. J Clin Endocrinol Metab 2003, 88:78.
3. Depo-Provera: FDA Physician Information. ; 2004. http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20246s025lbl.pdf.
4. Busen N.H., Britt R.B., Rianon N. Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years. JAdolesc Health 2003, 32:257.
5. Cromer B.A., Stager M., Bonny A., et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. JAdolesc Health 2004, 35:434.
6. Kass-Wolff J.H. Bone loss in adolescents using Depo-Provera. J Soc Pediatr Nurs 2001, 6:21.
7. Harel Z., Johnson C.C., Gold M.A., et al. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Contraception 2010, 81:281.
8. Rauch F., Plotkin H., DiMeglio L., et al. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions. J Clin Densitom 2008, 11:22.
9. Beksinska M.E., Kleinschmidt I., Smit J.A., et al. Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception. Contraception 2009, 80:128.
10. Khosla S., Melton L.J., Dekutoski M.B., et al. Incidence of childhood distal forearm fractures over 30 years: a population-based study. JAMA 2003, 290:1479.
11. Vestergaard P., Rejnmark L., Mosekilde L. The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women. Contraception 2008, 78:459.
12. Meier C., Brauchli Y.B., Jick S.S., et al. Use of depot medroxyprogesterone acetate and fracture risk. J Clin Endocrinol Metab 2010, 95:4909.
13. Gordon C.M., DePeter K.C., Feldman H.A., et al. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 2004, 158:531.
14. Harel Z., Riggs S., Vaz R., et al. Bone accretion in adolescents using the combined estrogen and progestin transdermal contraceptive method Ortho Evra: a pilot study. J Pediatr Adolesc Gynecol 2010, 23:23.
15. Harel Z., Wolter K., Gold M.A., et al. Inadequate vitamin D status in adolescents with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate injectable contraceptive: a pilot study. J Pediatr Adolesc Gynecol 2010, 23:209.
16. Gordon C.M., Bachrach L.K., Carpenter T.O., et al. Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions. J Clin Densitom 2008, 11:43.